Literature DB >> 30531525

Symptom Care at Home: A Comprehensive and Pragmatic PRO System Approach to Improve Cancer Symptom Care.

Kathi Mooney1, Meagan S Whisenant2, Susan L Beck3.   

Abstract

INTRODUCTION: There is growing recognition that systematically obtaining the patient's perspective on their health experience, using patient-reported outcomes (PRO), can be used to improve patient care in real time. Few PRO systems are designed to monitor and provide symptom management support between visits. Patients are instructed to contact providers between visits with their concerns, but they rarely do, leaving patients to cope with symptoms alone at home. We developed and tested an automated system, Symptom Care at Home (SCH), to address this gap in tracking and responding to PRO data in-between clinic visits. The purpose of this paper is to describe SCH as an example of a comprehensive PRO system that addresses unmet need for symptom support outside the clinic. METHODS FOR PRO SCORE
INTERPRETATION: SCH uses pragmatic, single-item measures for assessing symptoms, which are commonly used and readily interpretable for both patients and providers. We established alerting values for PRO symptom data, which was particularly important for conserving oncology providers' time in responding to daily PRO data. METHODS FOR DEVELOPING RECOMMENDATIONS FOR ACTING ON PRO
RESULTS: The SCH system provides automated, just-in-time self-management coaching tailored to the specific symptom pattern and severity levels reported in the daily call. In addition, the SCH system includes a provider decision support system for follow-up symptom assessment and intervention strategies. DISCUSSION: SCH provides PRO monitoring, tailored automated self-management coaching, and alerts the oncology team of poorly controlled symptoms with a provider dashboard that includes evidence-based decision support for follow-up to improve individual patients' symptom care. We particularly emphasize our process for PRO selection, rationale for determining alerting thresholds, and the design of the provider dashboard and decision support. Currently, we are in the process of updating the SCH system, developing both web-based and app versions in addition to interactive voice response phone access and integrating the SCH system in the electronic health record.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30531525      PMCID: PMC8087999          DOI: 10.1097/MLR.0000000000001037

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  47 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods.

Authors:  H J Gerbershagen; J Rothaug; C J Kalkman; W Meissner
Journal:  Br J Anaesth       Date:  2011-06-30       Impact factor: 9.166

3.  Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.

Authors:  Renée Simon; Jean Latreille; Claire Matte; Pierre Desjardins; Eric Bergeron
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

Review 4.  The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.

Authors:  Roxanne E Jensen; Nan E Rothrock; Esi M DeWitt; Brennan Spiegel; Carole A Tucker; Heidi M Crane; Christopher B Forrest; Donald L Patrick; Rob Fredericksen; Lisa M Shulman; David Cella; Paul K Crane
Journal:  Med Care       Date:  2015-02       Impact factor: 2.983

Review 5.  What can I do? Recommendations for responding to issues identified by patient-reported outcomes assessments used in clinical practice.

Authors:  Elizabeth F Hughes; Albert W Wu; Michael A Carducci; Claire F Snyder
Journal:  J Support Oncol       Date:  2012-05-18

6.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

Authors:  Ronald C Serlin; Tito R Mendoza; Yoshio Nakamura; Katherine R Edwards; Charles S Cleeland
Journal:  Pain       Date:  1995-05       Impact factor: 6.961

7.  Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities.

Authors:  Marcia M Boehmke; Suzanne S Dickerson
Journal:  Cancer Nurs       Date:  2005 Sep-Oct       Impact factor: 2.592

8.  Treatment with oral anticancer agents: symptom severity and attribution, and interference with comorbidity management.

Authors:  Sandra L Spoelstra; Charles W Given; Alla Sikorskii; Atreyee Majumder; Monica Schueller; Barbara A Given
Journal:  Oncol Nurs Forum       Date:  2015-01       Impact factor: 2.172

9.  Distinct Trajectories of Fatigue and Sleep Disturbance in Women Receiving Chemotherapy for Breast Cancer.

Authors:  Meagan Whisenant; Bob Wong; Sandra A Mitchell; Susan L Beck; Kathi Mooney
Journal:  Oncol Nurs Forum       Date:  2017-11-01       Impact factor: 2.172

10.  Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT.

Authors:  Kathi H Mooney; Susan L Beck; Bob Wong; William Dunson; Debra Wujcik; Meagan Whisenant; Gary Donaldson
Journal:  Cancer Med       Date:  2017-01-30       Impact factor: 4.452

View more
  6 in total

Review 1.  Advancing Oncology Nursing Practice Through the Adoption of Patient Monitoring Digital Tools.

Authors:  Christina M Wilson; Kathi Mooney
Journal:  Semin Oncol Nurs       Date:  2020-11-18       Impact factor: 2.315

2.  Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action.

Authors:  Samuel U Takvorian; Erin Balogh; Sharyl Nass; Virginia L Valentin; Lori Hoffman-Hogg; Randall A Oyer; Robert W Carlson; Neal J Meropol; Lisa Kennedy Sheldon; Lawrence N Shulman
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

3.  Feasibility randomised controlled trial of remote symptom chemotherapy toxicity monitoring using the Canadian adapted Advanced Symptom Management System (ASyMS-Can): a study protocol.

Authors:  Saeed Moradian; Monika Krzyzanowska; Roma Maguire; Vishal Kukreti; Eitan Amir; Plinio P Morita; Geoffrey Liu; Doris Howell
Journal:  BMJ Open       Date:  2020-06-17       Impact factor: 2.692

4.  Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program.

Authors:  Bastien Collomb; Amélie Dubromel; Anne Gaëlle Caffin; Chloé Herledan; Virginie Larbre; Amandine Baudouin; Ariane Cerutti; Laurence Couturier; Magali Maire; Lionel Karlin; Delphine Maucort-Boulch; Laure Huot; Stéphane Dalle; Emmanuel Bachy; Hervé Ghesquieres; Gilles Salles; Sébastien Couraud; Benoit You; Gilles Freyer; Véronique Trillet-Lenoir; Florence Ranchon; Catherine Rioufol
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

5.  Deploying the Behavioral and Environmental Sensing and Intervention for Cancer Smart Health System to Support Patients and Family Caregivers in Managing Pain: Feasibility and Acceptability Study.

Authors:  Virginia LeBaron; Ridwan Alam; Rachel Bennett; Leslie Blackhall; Kate Gordon; James Hayes; Nutta Homdee; Randy Jones; Kathleen Lichti; Yudel Martinez; Sahar Mohammadi; Emmanuel Ogunjirin; Nyota Patel; John Lach
Journal:  JMIR Cancer       Date:  2022-08-09

Review 6.  Informal caregiver burden for solid tumour cancer patients: a review and future directions.

Authors:  Kanjana Thana; Rebecca Lehto; Alla Sikorskii; Gwen Wyatt
Journal:  Psychol Health       Date:  2021-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.